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capsuleAbstract Biodegradable poly(D,L-lactide) (PDLLA), Poly(trimethylene carbonate) (PTMC),
polycaprolactone (PCL), poly(caprolactone-co-D,L-lactide) (PCDLLA) and poly(trimethylene car-
bonate-co-caprolactone) (PTCL) are recently used for clinical drug delivery system such as subcu-
taneous contraceptive implant capsule due to their biodegradable properties that they could possess
long-term stable performance in vivo without removal, however their permeation rate is unknown.
In the work, biodegradable material membranes were prepared by solvent evaporation using chlo-
roform, and commercial silicone rubber membrane served as a control. Gestodene was used as a
model drug. Gestodene has high biologic progestational activity which allows for high contracep-
tive reliability at very low-dose levels. The permeation rate of gestodene for several biodegradable
materials was evaluated. In vitro diffusion studies were done using Franz diffusion cells with a dif-
fusion area of 1.33 cm2. Phosphate buffer solution (PBS, pH 7.4), 10% methanol solution and dis-
tilled water were taken in donor and receiver chambers at temperature of 37 C respectively. The
in vitro experiments were conducted over a period of 24 h during which samples were collected
at regular intervals. The withdrawn samples were appropriately diluted and measured on UV–vis
spectrophotometer at 247 nm. Conclusion data from our study showed that permeation rate of
PCDLLA with CL ratio more than 70% could be more excellent than commercial silicone rubber
membrane. They may be suitable as a candidate carrier for gestodene subcutaneous contraceptive
implants in contraceptive ﬁelds.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
During the past decades, women had been looking forward to
alternatives to the short-acting contraceptives and there were
many studies with focus on long-acting contraceptives
(Baldwin and Edelman, 2013; Neukom et al., 2011; Ferreira
et al., 2014; Chen and Chen, 2007). Consistent use of short-act-
ing methods such as injectables and pills is under constant
414 D. Liu et al.threat from difﬁculty of the ‘surprise’ in case of a forgotten
pill, inconvenience of daily intake, onset of side effects and
other factors (Harel and Cromer, 1999; Lara-Torre and
Schroeder, 2002; Likis, 2002; Brache and Faundes, 2010).
Long-acting contraceptive methods such as intrauterine con-
traceptive device (Thonneau and Almont, 2008; Jacques
et al., 1986), implants (Bhatia et al., 2011) and injections
(Thurman et al., 2013; Rahimy et al., 1999) which could offer
a long-period effect with good compliance (Urdl et al., 2005)
and tolerance are more popular (Archer et al., 2004). Subcuta-
neous (SC) implantation (Zhang et al., 2011; Ma et al., 2006) is
currently the most common route of self-administering
biopharmaceuticals.
Gestodene (Stanczyk and Archer, 2014; Gao et al., 2009;
Mateˇjı´cˇek and Kuba´nˇ, 2007) – a progestin in the 19-nortestos-
terone series – today is widely used in recent years. Gestodene
differs from levonorgestrel in chemical structure results in a
shift in the conformational location of the 18-ethyl group
and accounts for differences in the pharmacokinetics of the
two steroids. Gestodene has high biologic progestational activ-
ity with respect to ovulation inhibition, endometrial morphol-
ogy, and binding afﬁnity to the progesterone receptor. This
potent progestational activity allows for high contraceptive
reliability at very low-dose levels (Shoupe, 1994). Gestodene
is considered an effective, well-tolerated contraceptive option.
Controlled release drug delivery system (Bresolin et al.,
2014; Campinez et al., 2013) is one of the most active ﬁelds
of research and development, because of its advantages such
as high-efﬁciency and low side effects. Coupled with this,
methods for evaluation of drug carriers are in the center of
attention. According to their degradation properties, carriers
for implants can be further classiﬁed into biodegradable and
non-biodegradable biopolymers such as silicone rubber.
Degradable biomaterials do not need subsequent surgical
removal after being implanted in bodies, a feature superior
to non-degradable biomaterials. Long-term reversible contra-
ceptives have been promoted as highly effective contraceptives
that could lower rates of unintended pregnancy and are often
viewed as particularly suitable methods for young women
(Hoggart et al., 2013). Biodegradable polymers have been
widely used and have greatly promoted the development of
drug release system because of their biocompatibility and bio-
degradability. The development of biotechnology and medical
technology has set higher requirements for biomedical
materials.
Franz diffusion cell experiments (Kshirsagar et al., 2012;
Rauma and Johanson, 2009) are emerging as a generally
accepted method in the ﬁeld of drug delivery. Although a
new subcutaneous product is only of value if the clinical phar-
macokinetic proﬁle appears the appropriate pharmacody-
namic response needed for the treatment of the patient,
preclinical assessments strongly guide the product develop-
ment. These include in vitro experiments for evaluating the
penetration of a drug molecule through the biodegradable
materials membranes. Moreover, measurement of the release
proﬁles of the active pharmaceutical ingredient from the for-
mulation is not only an important parameter for characterizing
its release behavior, but it can also be considered as a signiﬁ-
cant quality attribute which is valuable in the development
of a suitable formulation or in the evaluation of possible
changes in formulation composition, production parameters
and shelf-life stability (Vithlani et al., 2012; Boateng et al.,2012; Gao et al., 2014; Zare et al., 2008). Therefore, the regu-
latory health authorities are generally requesting these diffu-
sion-release tests in the pharmaceutical dossier submitted to
obtain the marketing authorization (Baert et al., 2011). In vitro
permeation experiments are a valuable adjunct to in vivo
absorption studies, and provide a convenient means for evalu-
ating the permeation characteristics of drugs (Jung et al., 2012;
Ng et al., 2012).
The purpose of this paper was to evaluate the permeation
properties of gestodene on several biodegradable materials
such as PTMC (Zhang et al., 2006; Kluin et al., 2009), PCL
(Shen et al., 2013; Yen et al., 2009), PDLLA (Guo et al.,
2007; Kumar et al., 2014), PCDLLA (Zhang et al., 2013b)
and PTCL (Campos et al., 2013), which are proved to be used
in human body by FDA (Tian et al., 2012; Ishaug-Riley et al.,
1999; San Miguel et al., 2008; Kowalczuk et al., 2014).
Although these biomaterials had been intensively studied, the
permeation proﬁles of these materials can be different, espe-
cially when considering certain drug delivery system and were
never reported. Gestodene was used as a model drug. The per-
meation studies, particularly for drug permeation, involved the
use of Franz-type diffusion cells. These consisted of two com-
partments with a membrane clamped between the donor and
receiver chambers. Such diffusion or permeation cells had a
ﬁxed volume of agitated donor and receptor solutions and
can then be used to evaluate the time course for permeation
of gestodene through these membranes. The concentration of
gestodene was measured by UV–vis spectrophotometry. The
method was previously validated and veriﬁed for accuracy,
precision and linearity. A comprehensive proﬁle of their prop-
erties comparing to commercial medical silicone rubber mem-
brane was also provided. The results obtaining from UV–vis
spectrophotometer clearly indicated that the diffusion cells
provide a simple, precise and reliable system to monitor
in vitro experiment.2. Materials and methods
2.1. Materials
1,3-Trimethylene carbonate (TMC, Jinan Daigang Biomaterial
Co., Ltd, China) and D,L-lactide (DLLA, Jinan Daigang Bio-
material Co., Ltd, China) were used without further puriﬁca-
tion. e-caprolactone (CL, Alfa Aesar, USA) was puriﬁed by
drying over CaH2 (Sinopharm Chemical Reagent Co., Ltd,
China) and distilled under reduced nitrogen pressure. Stan-
nous octoate (SnOct2, Sigma–Aldrich, USA) was used as
received. Gestodene was obtained from Beijing (China) Zizhu
Pharmaceutical Co., Ltd. Medical silicone rubber membrane
was received from Jinan (China) Chensheng Medical Silicone
Rubber Product CO., Ltd. Solvents used for the sample prep-
aration and analytical procedures were of HPLC or analytical
grade.
2.2. Polymer synthesis
PTMC, PCL, PDLLA, PCDLLA and PTCL were synthesized
as previously described (Yang et al., 2010; Zhang et al., 2012;
Zhang et al., 2013a). Brieﬂy, the polymerizations were con-
ducted by ring opening polymerization in evacuated and sealed
glass ampules using SnOct2 as catalyst (Feng et al., 2009).
Figure 1 Schematic drawing of the diffusion cell with thermo-
static water bath.
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synthesized polymers were puriﬁed by dissolution in chloro-
form and precipitation into methanol. After being washed in
methanol several times, the polymers were dried under reduced
pressure until constant weight.
2.3. Gel permeation chromatography (GPC) analysis
The molecular weight of gels and their distribution (Polydisper-
sity index, PDI) were measured by GPC using a Waters model
1515 isocratic HPLC pumpwith aWaters model 2414 refractive
index detector, at a ﬂow rate of 1.0 ml/min (eluent: THF; 35 C).
Polystyrene standards (Waters) were used for calibration.
2.4. Preparation of membranes
Homogeneous membranes were prepared from PDLLA,
PTMC, PCL, PCDLLA and PTCL by solvent evaporation
at room temperature as described (Bormashenko et al., 2006;
Tsuji and Miyauchi, 2001). Brieﬂy, polymers were dissolved
in chloroform. A total of 50 ml of the polymer solution were
cast into glass Petri dishes. The solvent was allowed to evapo-
rate slowly in a fume hood at room temperature. Finally the
membranes with a 15-cm diameter were weighed individually
and kept in a desiccator containing calcium chloride at room
temperature. The ﬁnal weight was noted when there was no
further change in the weight of individual membrane. Thick-
ness of the membranes was measured using a vernier caliper
at different places of the membrane and average thickness
determined was 0.022 cm.
2.5. In vitro permeation studies – Franz diffusion cell
In vitro diffusion studies were done using Franz diffusion cell
having a diffusion area of 1.33 cm2. This automation of such
experiments had increased in the last few years (Lobo et al.,
2014; Li et al., 2012). A protocol suitable to validate the
automated diffusion equipment with several in-line ﬂow-
through cells was used. The diffusion system was machined
with inlet and outlet where thermostatic water-circulator bath
can be attached. The temperature was precisely controlled in
a thermostatic cabinet to minimize variations in experimental
conditions (4T 6 1 C). The Franz diffusion cell system
designed, constructed and operated in this study is shown
schematically in Fig. 1. PBS, 10% methanol solution and dis-
tilled water were taken in donor and receiver chambers at
37 C for 24 h respectively. The prepared membranes sepa-
rated the two chambers. Saturated solution of Gestodene
was placed in the donor chamber, and corresponding solvent
was placed in receiver chamber. The contents of the both
chambers were stirred continuously at about 150 rpm using
a magnetic bead. 6 ml of the solution from the receiver med-
ium was removed at regular intervals, 0, 0.5, 1, 2, 3, 6, 8, 12,
and 24 h and was replaced with equal volume of fresh solvent
to maintain sink conditions. All the determinations were
made in triplicate for each cell.
2.6. UV–vis spectroscopy
Solutions removed from receptor chamber were taken for drug
content estimation. The solution samples were ﬁltered through0.45 lm ﬁlter membranes and analyzed for the determination
of gestodene permeated. UV–vis absorption measurement
was carried out at room temperature on a PerkinElmer lambda
20 UV–vis spectrometer using a quartz cell. A dilute solution
was used for this analysis. The UV–vis spectrum of gestodene
in the range of 190–400 nm was obtained. Finally, the ﬁltrate
was examined for the drug content by measuring absorbance
at kmax of 247 nm. The cumulative gestodene release was inves-
tigated. The unknown concentrations of the remained solu-
tions were determined using the equation obtained from the
standard curve, A= 0.0528C (lg/ml) – 0.0078, with a correla-
tion coefﬁcient of R2 = 0.99999.
3. Results and discussion
3.1. Macroscopic observations
Membrane-forming capabilities of biodegradable polymers
were different (Table 1). The membranes morphology was
found to be homogeneous for most of materials, except for
small molecular weight PDLLA. However, it was also difﬁcult
to remove the membrane from Petri dish for PCDLLA
(40:60 mol%) due to its viscosity. The permeation experiments
could not be carried out for small molecular weight PDLLA
and PCDLLA (40:60 mol%) membranes.
3.2. Molecular weight and distribution analysis by GPC
Table 2 shows number molecular weight of different materials
before and after membrane-forming. In drug delivery systems,
a moderate molecular weight was desired, which can affect the
polymer properties such as morphology, membrane-forming,
and permeation rate, directly. We aimed at searching the opti-
mal molecular weight of different biodegradable materials in
the experiment for permeation studies. As a little change
in the molecular weight of materials before and after
Table 1 Comparison of membrane-forming capabilities for different materials.
Polymer Molar ratio Mn · 105 Membrane-forming capabilities
PTMC17 – 17 Fine; easy to be removed from Petri dishes; ﬂexible; transparent; adhesive
PTMC22 – 22
PTMC29 – 29
PCL6 – 6 Fine; easy to be removed from Petri dishes; slightly hard; a white appearance
PCL10 – 10
PCL16 – 16
PDLLA4 – 4 Diﬃcult to separate them from Petri dishes
PDLLA5 – 5
PDLLA7 – 7 Fine; easy to be removed from Petri dishes; slightly hard; transparent
PDLLA12 – 12
PDLLA17 – 17
PCDLLA1:9 10:90 13 Fine; easy to be removed from Petri dishes; moderate hard; anti-adhesive
PCDLLA2:8 20:80 15
PCDLLA3:7 30:70 10
PCDLLA4:6 40:60 15 Fine; ﬂexible; adhesive
PCDLLA5:5 50:50 17
PCDLLA6:4 60:40 15 Very poor; diﬃcult to separate them from Petri dishes
PCDLLA7:3 70:30 20 Fine; easy to be removed from Petri dishes; moderate hard; anti-adhesive
PCDLLA8:2 80:20 16
PCDLLA9:1 90:10 15
PTCL1:9 10:90 25
PTCL2:8 20:80 24
PTCL3:7 30:70 23
PTCL4:6 40:60 23 Fine; easy to be removed from Petri dishes; anti-adhesive
PTCL5:5 50:50 25 An increase in hardness and opaqueness was correlated with increased caprolactone molar ratio
PTCL6:4 60:40 25
PTCL7:3 70:30 25
PTCL8:2 80:20 26
PTCL9:1 90:10 26
Table 2 Number molecular weight of different polymers before and after membrane-forming.
Polymer Molar ratio Mn · 105
Before membrane-forming After membrane-forming
PTMC17 – 17 16
PTMC22 – 22 22
PTMC29 – 29 28
PCL6 – 6 6
PCL10 – 10 9
PCL16 – 16 16
PDLLA7 – 7 6
PDLLA12 – 12 10
PDLLA17 – 17 15
PCDLLA1:9 10:90 9 10
PCDLLA2:8 20:80 11 9
PCDLLA3:7 30:70 10 9
PCDLLA4:6 40:60 11 9
PCDLLA5:5 50:50 11 10
PCDLLA6:4 60:40 10 8
PCDLLA7:3 70:30 13 10
PCDLLA8:2 80:20 10 10
PCDLLA9:1 90:10 10 8
PTCL1:9 10:90 25 24
PTCL2:8 20:80 24 22
PTCL3:7 30:70 23 23
PTCL4:6 40:60 23 22
PTCL5:5 50:50 25 23
PTCL6:4 60:40 25 24
PTCL7:3 70:30 25 23
PTCL8:2 80:20 26 25
PTCL9:1 90:10 26 24
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Figure 2 Permeation proﬁles of gestodene through different type
of homopolymers and silicone rubber after 24 h.
Figure 3 Permeation proﬁles of gestodene through various
molar ratios of PCDLLA copolymers and silicone rubber after
24 h.
Table 3 Effect of molecular weight and release media on
permeation efﬁcacy for homopolymer.
Polymer Mn · 105 Permeation eﬃcacy
Water PBS Methanol
PTMC17 17 +++ +++ +++++
PTMC22 22 ++ ++ +++++
PTMC29 29 ++ + +++
PCL6 6 +++ +++ ++++
PCL10 10 ++ ++ +++
PCL16 16 ++ ++ ++
PDLLA7 7 + + ++
PDLLA12 12  + +++
PDLLA17 17 + + ++
Cumulative drug release after 24 h was used for the comparison.
The number of signs represented different cumulative drug release
values: , <2 lg; +, 2–5 lg; ++, 5–10 lg; +++, 10–15 lg;
++++, 15–20 lg; +++++, >20 lg.
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tion method did not affect the molecular weight values of these
materials.Table 4 Effect of molar ratio and release media on permeation efﬁ
Copolymer Molar ratio Permea
Water
PCDLLA1:9 10:90 ++++
PCDLLA2:8 20:80 ++++
PCDLLA3:7 30:70 ++++
PCDLLA4:6 40:60 ++++
PCDLLA5:5 50:50 +++
PCDLLA6:4 60:40 ++
PCDLLA7:3 70:30 ++
PCDLLA8:2 80:20 ++
PCDLLA9:1 90:10 ++
Cumulative drug release after 24 h was used for the comparison. The num
<2 lg; +, 2–5 lg; ++, 5–10 lg; +++, 10–15 lg; ++++, 15–20 lg;PDI was deﬁned as the ratio of the weight average molecu-
lar weight, Mw, to the number average molecular weight, Mn.
High PDI values correspond to a conglomerate of chains span-
ning a wide range of molecular weights. The lower values in
PDI indicated that homogeneous polymers were synthesized.
3.3. Permeation studies
3.3.1. Constant homopolymer but varying molecular weight and
release media
As shown in Table 3 and Fig. 2, total cumulative release within
24 h was lower than 15 lg. When the molecular weight of des-
ignated homopolymer was constant, the permeation rate was
not similar to that observed in different media and lower than
that obtained with the silicone rubber, suggesting that these
homopolymers have lower permeation efﬁcacy than that of
commercial rubber silicone product.
The summed results of the permeation rate, as shown in
Fig. 2, indicated that permeation rate was affected by both
molecular weight and release media, but no signiﬁcant differ-
ence was observed in release proﬁles.cacy for copolymer PCDLLA.
tion eﬃcacy
PBS Methanol
+ +++++ +++++
+ +++++ +++++
+ +++++ +++++
+ ++++ +++++
+++ +++++
++ +++
++ +++
++ ++
+ ++
ber of signs represented different cumulative drug release values: ,
+++++, >20 lg.
Figure 4 Permeation proﬁles of gestodene through various
molar ratios of PTCL copolymers and silicone rubber after 24 h.
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varying molar ratio and release media
The results obtained from Table 4 and Fig. 3 showed that the
high molar ratio of caprolactone part in copolymer and the
high permeation efﬁcacy of copolymers were exhibited.
Among these release media, the maximal permeation rate
was occurred in 10% methanol solution. The permeation rate
of copolymer in PBS or 10% methanol solution appeared the
remarkable decrease with the decrease in the molar ratio of
caprolactone. However, the permeation rate of copolymer in
distilled water decreased slightly with the decrease in the molar
ratio of caprolactone.
The release of gestodene from different membranes could
be best described by cumulative release values from Fig. 3.
Cumulative drug release of commercial silicone rubber mem-
brane was found to be more than 30 lg/d which indicating that
commercial silicone rubber membrane had good permeation
performance in different media.
In the permeability experiments using the Franz diffusion
cells, the permeation efﬁcacy of copolymers was correlated
with molar ratio of caprolactone. In general, drug permeation
of copolymers was larger with a range of caprolactone molarTable 5 Effect of molar ratio and release media on permeation efﬁ
Copolymer Molar ratio Permeat
Water
PTCL1:9 10:90 +++
PTCL2:8 20:80 +++
PTCL3:7 30:70 +++
PTCL4:6 40:60 ++++
PTCL5:5 50:50 ++++
PTCL6:4 60:40 +++
PTCL7:3 70:30 +++
PTCL8:2 80:20 +++
PTCL9:1 90:10 ++
Cumulative drug release after 24 h was used for the comparison. The nu
<2 lg; +, 2–5 lg; ++, 5–10 lg; +++, 10–15 lg; ++++, 15–20 lgratios, from 70 to 90, especially in 10% methanol solution.
The permeation rate of copolymers in methanol can reach a
maximum of 60.12 lg/d, whereas the molar ratio value should
be 80%. When the molar content of caprolactone part in PCD-
LLA was 90%, the permeation results of copolymer were sim-
ilar to those of commercial silicone rubber membranes. It can
be explained by the fact that copolymers with a range of cap-
rolactone molar ratios from 70 to 90 have a signiﬁcant lipo-
philic property. Copolymers showed more outstanding
permeability data than those of homopolymers for gestodene,
generally.
3.3.3. Constant molecular weight of copolymer PTCL but
varying molar ratio and release
The permeation properties of the copolymers PTCL in differ-
ent media were investigated and the results are shown in Fig. 4
and Table 5. The overall drug release of PTCL gradually
increased with time in distilled water, methanol and PBS.
However, the cumulative release was found to be low when
the molar ratio was far away from 1:1 and close to homopol-
ymer. The results observed were consistent with those of
homopolymers we had been summarized. Gestodene release
proﬁles of homopolymers were not excellent in the current
study. The release results also demonstrated that the slightly
high cumulative drug release in methanol medium is mainly
due to the higher degree of swelling of the polymer matrix in
methanol. This polymer chain–solution interaction decreases
the physical cross-linking between PTCL chains and allowing
a slightly higher degree of swelling of the polymer matrix
and follows a more complete release of gestodene.
4. Conclusion
Biodegradable materials based drug delivery formulations
research has reached signiﬁcant maturity in the last few years
(Dash and Konkimalla, 2012). There are numerous compelling
evidences for the potential of biodegradable materials for
many novel challenging drug delivery and tissue engineering
applications. It is worth mentioning that the outstanding per-
meation efﬁcacy of these membranes obviously offers immense
potential in drug delivery systems.
Various homopolymers and copolymers membranes were
prepared using the solvent evaporation method for permeation
studies and commercial silicone rubber membrane was selectedcacy for copolymer PTCL.
ion eﬃcacy
PBS Methanol
++ +++
+++ +++
++++ +++++
+ +++++ +++++
+ +++++ +++++
++++ +++++
++++ +++++
+++++ +++++
++ ++++
mber of signs represented different cumulative drug release values: -,
; +++++, >20 lg.
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experiment.
When comparisons were made among these materials, it
was found that there were some differences in the release of
gestodene. It was reported that there are contraceptive
implants, containing 42 mg gestodene. And effective release
area was 2.26 cm2. Effective dose of gestodene of preventing
pregnancy was reported to be in the range of 10–20 lg/d
(Chen et al., 1996). However, Franz diffusion cells had a diffu-
sion area of 1.33 cm2 in the present studies. After the corre-
sponding conversion of diffusion area to silicone rubber
membrane, permeation rate of PCL in different media was
greater than or close to 10 lg/d; almost permeation rate of
all the PDLLA copolymers in different media was less than
10 lg/d, except for the one whose molecular weight was
120,000 in 10% methanol solution; the PCDLLA copolymers,
ranging in molar ratio of caprolactone from 70 to 90, exhibited
excellent permeation performance similar to commercial sili-
cone rubber membrane; the PTCL copolymers exhibited supe-
rior permeation characteristics, when the molar ratio of
trimethylene carbonate to caprolactone was close to 1. Details
of the overall permeation data can be put into evidence and
analyzed in drug delivery system research in the future.Acknowledgments
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